v3.25.4
Revenue Recognition (Tables)
12 Months Ended
Dec. 31, 2025
Revenue Recognition [Abstract]  
Schedule of Disaggregated Revenue
Segment Net Sales
MedSurg and Neurotechnology:
2025
2024
2023
Instruments
$3,183
$2,834
$2,534
Endoscopy
3,807
3,389
3,068
Medical
4,204
3,852
3,459
Vascular
1,968
1,307
1,226
Neuro Cranial
2,485
2,136
1,876
$15,647
$13,518
$12,163
Orthopaedics:
Knees
$2,656
$2,447
$2,273
Hips
1,865
1,704
1,544
Trauma and Extremities
3,948
3,507
3,147
Spinal Implants
185
707
713
Other
815
712
658
$9,469
$9,077
$8,335
Total
$25,116
$22,595
$20,498
United States Net Sales
MedSurg and Neurotechnology:
2025
2024
2023
Instruments
$2,562
$2,267
$2,016
Endoscopy
3,133
2,792
2,513
Medical
3,510
3,191
2,785
Vascular
1,048
506
483
Neuro Cranial
2,052
1,761
1,531
$12,305
$10,517
$9,328
Orthopaedics:
Knees
$1,924
$1,788
$1,676
Hips
1,137
1,059
988
Trauma and Extremities
2,926
2,586
2,297
Spinal Implants
118
489
500
Other
596
504
468
$6,701
$6,426
$5,929
Total
$19,006
$16,943
$15,257
International Net Sales
MedSurg and Neurotechnology:
2025
2024
2023
Instruments
$621
$567
$518
Endoscopy
674
597
555
Medical
694
661
674
Vascular
920
801
743
Neuro Cranial
433
375
345
$3,342
$3,001
$2,835
Orthopaedics:
Knees
$732
$659
$597
Hips
728
645
556
Trauma and Extremities
1,022
921
850
Spinal Implants
67
218
213
Other
219
208
190
$2,768
$2,651
$2,406
Total
$6,110
$5,652
$5,241
Changes in Contract Liabilities Changes in
contract liabilities during the year were as follows:
2025
2024
Beginning contract liabilities
$978
$860
Revenue recognized from beginning of year contract
liabilities
(546)
(553)
Net advance consideration received during the period
592
671
Ending contract liabilities
$1,024
$978